CytomX Therapeutics
CTMX
#9633
Rank
โ‚ฌ39.3 M
Marketcap
0,49ย โ‚ฌ
Share price
-10.78%
Change (1 day)
-75.26%
Change (1 year)

EPS for CytomX Therapeutics (CTMX)

EPS in 2023 (TTM): -0,81ย โ‚ฌ

According to CytomX Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,76ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -1,54ย โ‚ฌ an increase over its 2021 EPS that were of -1,64ย โ‚ฌ.

EPS history for CytomX Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,81ย โ‚ฌ-47.45%
2022-1,54ย โ‚ฌ-6.04%
2021-1,64ย โ‚ฌ30.94%
2020-1,26ย โ‚ฌ-52.56%
2019-2,65ย โ‚ฌ45.05%
2018-1,83ย โ‚ฌ72.65%
2017-1,06ย โ‚ฌ-27.78%
2016-1,46ย โ‚ฌ35.65%
2015-1,08ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,97ย โ‚ฌ 159.52%๐Ÿ‡บ๐Ÿ‡ธ USA